These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24060850)

  • 1. Hepatitis C: a mouse at the end of the tunnel.
    Binder M; Bartenschlager R
    Cell Res; 2013 Dec; 23(12):1343-4. PubMed ID: 24060850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-1 and its potential role in HCV entry: another piece of the puzzle.
    Hamilton JP; Thuluvath PJ
    J Clin Gastroenterol; 2008 Jan; 42(1):3-4. PubMed ID: 18097281
    [No Abstract]   [Full Text] [Related]  

  • 3. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
    Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
    Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virology: Final entry key for hepatitis C.
    Pietschmann T
    Nature; 2009 Feb; 457(7231):797-8. PubMed ID: 19212389
    [No Abstract]   [Full Text] [Related]  

  • 5. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
    Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
    BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-specific regions of occludin required by hepatitis C virus for cell entry.
    Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
    J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes.
    Park IW; Ndjomou J; Fan Y; Henao-Mejia J; He JJ
    Biochem Biophys Res Commun; 2009 Sep; 387(3):489-93. PubMed ID: 19619513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
    Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
    Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus host cell entry.
    Ploss A; Evans MJ
    Curr Opin Virol; 2012 Feb; 2(1):14-9. PubMed ID: 22440961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Putative hepatitis C virus cell receptors].
    Farafonova TE; Olenina LV; Kolesanova EF
    Biomed Khim; 2008; 54(2):154-66. PubMed ID: 18522217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus entry.
    Zeisel MB; Felmlee DJ; Baumert TF
    Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe.
    Monrroy H; López-Lastra M; Soza A
    Med Hypotheses; 2017 May; 102():51-55. PubMed ID: 28478831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
    Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
    J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetically humanized mouse model for hepatitis C virus infection.
    Dorner M; Horwitz JA; Robbins JB; Barry WT; Feng Q; Mu K; Jones CT; Schoggins JW; Catanese MT; Burton DR; Law M; Rice CM; Ploss A
    Nature; 2011 Jun; 474(7350):208-11. PubMed ID: 21654804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for the study of hepatitis C virus infection and replication.
    MacArthur KL; Wu CH; Wu GY
    World J Gastroenterol; 2012 Jun; 18(23):2909-13. PubMed ID: 22736914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus entry: beyond receptors.
    Meredith LW; Wilson GK; Fletcher NF; McKeating JA
    Rev Med Virol; 2012 May; 22(3):182-93. PubMed ID: 22392805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
    Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
    [No Abstract]   [Full Text] [Related]  

  • 20. A master regulator of tight junctions involved in hepatitis C virus entry and pathogenesis.
    Denolly S; Cosset FL
    Hepatology; 2017 May; 65(5):1756-1758. PubMed ID: 28177536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.